Antidiabetics Market is Expected to Cross USD 80.0 Billion by 2022
Global Antidiabetics Market is anticipated to cross USD 80.0 Billion by 2022 growing at a CAGR of more than 9.5 % in the given forecast period.
Browse Full Report: https://www.marketresearchengine.com/reportdetails/antidiabetics-market
Ant diabetics are the drugs which stabilize the glucose levels in blood. These medicines also control and lower the levels of glucose in blood for diabetic patients. Most common type of antidiabetics is insulin. A periodic shot of insulin generally long acting type is prescribed for diabetic patients to regulate glucose levels.
Increasing number of diabetic patients is increasing the demand for antidiabetics which is a driving factor for antidiabetics market. Increased use of insulin is a growth factor for this market. Insulin leads the global market with the largest market share by revenue and anticipated to have sharp growth. Increase in rates of obesity is obliquely driving the antidiabetics market. North America hold the largest share in antidiabetics market as it holds highest rate of obesity in the world, which is one of the major reason for cause of diabetics.
The global antidiabetics market was valued at USD 41,305.7 million in 2013 and is expected to grow at a CAGR of more than 9.5% during the forecast period.
The global antidiabetics market is segmented based on its product which includes thiazolodinediones, glp-agonists, sulphonylureas, dpp-4 inhibitors, sglt-2, alpha-glucosidase inhibitors, biguanides and meglitinides. The insulin is segmented as rapid acting, long acting, premixed, premixed analog, short acting and intermediate acting. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW).
This report provides:
1) An overview of the global market for antidiabetics and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for acetic acid market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The scope of the report includes a detailed study of global and regional markets for various types of coatings with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Sanofi-Aventis, Eli Lilly, Oramed Pharmaceuticals, Boehringer Ingelheim, Merck & Co. Inc., Bristol-Myers Squibb, Novo Nordisk, Halozyme Therapeutics, Pfizer and Takeda Pharmaceuticals. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Antidiabetics Market has been segmented as below:
By Types of Insulin
• Rapid Acting
• Long Acting
• Premixed Analog
• Short Acting
• Intermediate Acting
• DPP-4 inhibitors
• Alpha-glucosidase Inhibitors
• North America
• Rest of the World (ROW)
Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.
Company Name: Market Research Engine
Contact Person: John Bay
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidiabetics Market is Expected to Cross USD 80.0 Billion by 2022 here
News-ID: 535623 • Views: 219
More Releases from Market Research Engine Report
3D Printing Materials Market is Expected to Exceed USD 1400 Million by 2020
The 3 D Printing Materials Market is segmented based on material type, form and application. The 3 D Printing Materials Market is segmented based on material type as Plastics, Metals, Ceramics, Others. The 3 D Printing Materials Market is segmented based on form as Filament, Powder, Liquid. The 3 D Printing Materials Market is segmented based on application as Aerospace & defense, Medical & dental, Automotive, Consumer Goods,
Titanium Dioxide Market is Expected to Reach US$ 21 Billion by 2021
The global titanium dioxide market by application is segmented as paints & coatings, pulp & paper, plastics, cosmetics and other applications. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/titanium-dioxide-market How Big is the Global Titanium Dioxide Market? Global titanium dioxide market was accounted USD 15.5 billion in 2015. The revenue of this market is anticipated to increase
IoT Healthcare Market in North America is Expected to Grow at CAGR of 43% by 202 …
The IoT healthcare market is divided into technologies and services. The technologies segment is again analyzed by network technologies and applications technologies. The network technologies are further segmented to short range technologies and long-range technologies which are equally vital top form a connected ecosystem of healthcare. The service market is analyzed by consulting, integration and maintenance. The solution segment contributes to a majority part of the market. Browse Full Report
Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion …
The Nonalcoholic Steatohepatitis market is segmented on the lines of its Therapeutics such as GFT505, Obeticholic Acid (INT-747) Simtuzumab and Liraglutide (Victoza)Vitamin EPioglitazonePlacebo. The Nonalcoholic Steatohepatitis market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Browse Full Report @: https://www.marketresearchengine.com/reportdetails/non-alcoholic-steatohepatitis-nash-market How Big is the Global Nonalcoholic Steatohepatitis (NASH) Market? Global Non-Alcoholic Steatohepatitis (NASH) market is expected to cross US$ 20.0 Billion by